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locus in P. morum than in other
volvocacean species? Or is all the
variation between syngens in the
genes whose expression is
regulated by MID? And, finally (at
least for the moment), what are the
genes that are under the control of
the MID locus, and how different
are they in isogamous and
oogamous species?
It appears that the breakthrough
reported by Nozaki et al. [11] will
provide enough exciting new
opportunities to keep them and
many other investigators busy for
some time to come!
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A cell responds to a chemotactic signal by activating actin
polymerization and forming a protrusion oriented towards the source.
Recent work shows that the activity of cofilin, a protein that creates new
barbed ends for actin filament elongation, amplifies and specifies the
direction of the response in carcinoma cells.Sarah E. Hitchcock-DeGregori
Chemotaxis is the response of
a cell to an extracellular diffusible
or matrix-bound chemical signal
that results in movement towards
or away from the chemical, up or
down a gradient. The signal
molecule binds to a cell-surface
receptor and the information is
translated and amplified to
stimulate local, directionally
specific movement. While the
signals and pathways for
transmitting the information vary, in
eukaryotes the actin cytoskeleton
carries out the directional
movement of the cell, via effects
on actin polymerization and
actin–myosin interactions.
Fundamental biological
processes, including gastrulation,migration of neurons during the
establishment of the nervous
system in development, immune
responses, wound healing, and
cancer cell migration during
metastasis, depend on chemotaxis
[1,2]. The mechanisms of
chemotaxis have been intensively
investigated in Dictyostelium, the
social amoeba that responds to
cyclic AMP when it becomes
aggregation competent [3]. The
other classic system for the study
of chemotaxis is neutrophils, which
respond to small peptides, such as
fMLP produced by bacteria, and
migrate to sites of infection where
they phagocytose the bacteria [4].
Much has been learned about the
pathways in Dictyostelium and
neutrophils that lead to
redistribution of signaling andcytoskeletal proteins and
activation of the actin cytoskeleton
resulting in polarization and
directional migration [1,2].
Following stimulation, the leading
edge of the cell is driven forward
by actin polymerization on new,
fast-growing filament ends created
by cofilin and nucleation of
branches by the Arp2/3 complex,
as well as elongation promoted by
Ena/Vasp and formin families of
proteins. The rear of the cell then
follows via actin–myosin-mediated
contraction.
A remaining question is, how are
proteins in the signaling pathway
that are abundant and widely
distributed in an inherently
non-polar cell activated to result
in migration in a precise direction,
up or down a chemical gradient?
To address the question requires
the ability to manipulate the
molecules in the pathway and to
monitor the results in space and
in time. Progress has been made in
metastatic breast carcinoma cells
that undergo chemotaxis in
response to epidermal growth
factor (EGF), a model for cancer
metastasis [5]. These cells are large
and flat compared with
Dispatch
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neutrophils, making it possible to
quantify images at the cellular and
subcellular levels. The response
takes place in the order of minutes,
versus seconds, allowing
resolution of the kinetics of the
stages of the response in
conjunction with live-cell imaging
analysis.
The chemotactic response is
biphasic with two transients of
actin polymerization controlled by
different signaling mechanisms
[6,7], though the signaling
mechanisms are cell-type specific.
In carcinoma cells, the first phase,
within one minute after EGF
stimulation, requires activation of
cofilin via phospholipase C (PLC)
that, together with the Arp2/3
complex, results in formation of
a dendritic array of new actin
filaments that leads to protrusion of
a lamellipodium [8,9]. The second
transient of barbed-end actin
polymerization, three minutes after
stimulation and regulated by
phosphatidylinositol-3 kinase
(PI 3-kinase), is required for motility
but not protrusion [10].
Suppression of PLC or cofilin
activity inhibits the sensing of the
EGF gradient by the cells and leads
to inhibition of the initial response,
showing that cofilin is the key
molecule for activation of
the first transient of actin
polymerization.
A paper in a recent issue of
Current Biology joins a series of
elegant studies from the Condeelis
lab to unravel themechanism of the
chemotactic response in
carcinoma cells. In this work,
Mouneimne and colleagues [11]
dissected the spatial and temporal
regulation of cofilin activity. Cofilin,
a protein that can create new
barbed ends that serve to nucleate
rapid actin polymerization [12], is
regulated in at least two ways. The
most well-known regulator is LIM
kinase-1, which phosphorylates
cofilin, leading to its inactivation.
PLC may also regulate cofilin
by hydrolyzing bound
phosphatidylinositol (4,5)
bisphosphate (PIP2): given that
PIP2 inhibits the binding of cofilin to
actin in vitro [13], hydrolysis may
result in cofilin activation. Before
EGF activation, most of the cofilin
in the cell is inactive, even though itF BC
EGF
Cofilin activity
PLC activity
Unphosphorylated cofilin
Phosphorylated cofilin
C
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Figure 1. Diagram showing changes in the state and activity of cofilin, and its regula-
tor, in a carcinoma cell in response to EGF.
The colors represent idealized gradients of proteins and activities in an unstimulated,
resting cell (top) and in a cell 60 seconds after stimulation by EGF locally released at
the tip of a pipette (bottom). The color key applies to both panels. C is the centroid of
the cell; F is the ‘front’ of the cell, the point of cellular protrusion in response to localized
EGF release; B is the ‘back’ of the cell. The protrusion is drawn to be in line with the
pipette tip and the centroid. The angle between this line and the pipette tip is used to
calculate a ‘chemotactic index’ [11]. In the resting cell, even though the level of unphos-
phorylated cofilin is high, cofilin activity (measured in terms of actin filaments growing at
the barbed ends) is low, as are the PLC activity and the levels of phosphorylated cofilin.
After activation, there is local activation of PLC and global activation of LIMK, the kinase
that phosphorylates cofilin. PLC activity and unphosphorylated cofilin follow the EGF
gradient from the site of release, reflected in similar gradients of color saturation from
the front to the back of the cell. By comparison, cofilin activity is amplified 11-fold com-
pared to the EGF gradient, illustrated by a higher level of saturation at the site of protru-
sion and a steeper gradient away from the EGF source than is observed with PLC and
unphosphorylated cofilin. Mouneimne and colleagues [11] carried out a series of experi-
ments regulating the levels of cofilin and cofilin activity that indicated that local control
of cofilin activity is important for amplification of the EGF signal and directional forma-
tion of protrusions. (Figure produced with the help of Vladimir Leontiev.)is unphosphorylated, indicating
a higher level of control, the details
of which are not yet clear. After EGF
stimulation, PLC activity increases,
as does that of LIMK1, PLC’s
cofilin antagonist [9,14]. Using
a combination of methods to
regulate selectively cofilin activity,
previous work has shown that localactivation of cofilin by PLC at the
leading edge formed after EGF
stimulation is required for directed
protrusion, while phosphorylation
by LIMK1 inactivates cofilin in the
rest of the cell. The new work [11]
combines spatial and temporal
analyses of cells in which cofilin
activity is regulated to show that
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amplification and directional
specification of the chemotactic
response in breast carcinoma cells.
Together the work places cofilin in
the driver’s seat to control the
localized production of the actin
filaments that define directional
protrusion, the first morphological
manifestation of chemotaxis.
To arrive at this conclusion, the
authors developed methods to
create and quantify an EGF
gradient, and the cell’s response to
the gradient. A gradient was
created by releasing EGF at
a pipette tip, and a decreasing
gradient was calculated from that
point (Figure 1). The trajectory of
the protrusion was measured and
the angle of the protrusion relative
to a line passing between the
pipette tip and the centroid of the
cell was used to calculate
a ‘chemotactic index’. The present
studies revealed that cofilin is
essential for directional sensing:
suppression of cofilin with siRNA
resulted in formation of protrusions
in all directions, as did elevation of
LIMK1 or overexpression of
a constitutively active or inactive
cofilin mutant, all pointing to the
importance of local control of
cofilin activity for directional
formation of protrusions. The
chemotactic index was measured
in cells in which the levels and
activities of cofilin, LIMK1 and
PLC activity were individually
regulated, in conjunction with the
localization of the active forms of
the proteins. The experiments
that globally altered cofilin activity
were complemented by specific
immunostaining of cofilin, and its
inactive, phosphorylated form.
After activation, phosphocofilin
increases at the front and
back of the cell, whereas
unphosphorylated cofilin
preferentially accumulates at the
protruding end of the cell,
consistent with a role in protrusion
formation. The global activation
of LIMK1 was proposed to be
crucial for preventing the spread
of cofilin activation to other
regions of the cell. Similarly, an
antibody that recognizes the
phosphorylated, active form of
PLC was elevated at the front of
the cell, leading to the suggestion
that hydrolysis leads to the localrelease of PIP2 and activation of
cofilin. The gradients of cofilin and
phosphorylated PLC after
activation are comparable to the
EGF gradient (Figure 1). The
functional readout of cofilin
activity, that is, the creation of new
barbed ends for actin filament
polymerization, was also localized
at the site of the protrusion, but
in this case amplified 11-fold
relative to the EGF gradient.
This latest advance in our
understanding of how a rapid local
response is mounted on the part of
globally expressed molecules will
undoubtedly have sequels. As
Sydney Brenner once told
a class of students, one of whom
was me, ‘‘The most important
thing is to know what experiment
you will do tomorrow!’’. There is
no shortage of good questions,
just of clear answers. For example,
how do the inactivation of cofilin
by LIMK1 and activation of cofilin
by PLC compete with each
other? How is cofilin locally
protected from phosphorylation
if LIMK1 is globally active? Are
slingshot phosphatases (that
dephosphorylate cofilin) and
14-3-3zeta (a protein that binds to
and stabilizes phosphorylated
cofilin) coordinated with LIMK1, as
they are in other systems [15,16]?
Is the cofilin outside the active
region inhibited by both PLC and
PIP2 binding? Since it is already
clear that not all chemotactic,
directionally migrating cells follow
the same path to the destination
[1,2,12], it would be worthwhile
investigating other systems that
are amenable to the elegant
analyses that have been possible
in the carcinoma cells.
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